tiprankstipranks
Trending News
More News >
Pluri Inc. (PLUR)
:PLUR
Advertisement

Pluri (PLUR) Price & Analysis

Compare
973 Followers

PLUR Stock Chart & Stats

$4.52
-$0.22(-4.74%)
At close: 4:00 PM EST
$4.52
-$0.22(-4.74%)

Pluri News

PLUR FAQ

What was Pluri Inc.’s price range in the past 12 months?
Pluri Inc. lowest stock price was $3.33 and its highest was $7.13 in the past 12 months.
    What is Pluri Inc.’s market cap?
    Pluri Inc.’s market cap is $35.77M.
      When is Pluri Inc.’s upcoming earnings report date?
      Pluri Inc.’s upcoming earnings report date is Feb 11, 2025 which is 246 days ago.
        How were Pluri Inc.’s earnings last quarter?
        Currently, no data Available
        Is Pluri Inc. overvalued?
        According to Wall Street analysts Pluri Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Pluri Inc. pay dividends?
          Pluri Inc. does not currently pay dividends.
          What is Pluri Inc.’s EPS estimate?
          Pluri Inc.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Pluri Inc. have?
          Pluri Inc. has 8,155,948 shares outstanding.
            What happened to Pluri Inc.’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Pluri Inc.?
            Currently, no hedge funds are holding shares in PLUR

            Company Description

            Pluri Inc.

            Pluri (PLUR) is a company operating in the technology sector, focusing on developing innovative software solutions designed to enhance digital experiences across various industries. The company specializes in creating platforms that leverage cutting-edge technologies to improve user engagement and optimize business processes.
            Similar Stocks
            Company
            Price & Change
            Follow
            Tempest Therapeutics
            Daré Bioscience
            Clene
            Neurosense Therapeutics Ltd.
            CytoMed Therapeutics Limited

            Ownership Overview

            28.28%0.04%0.16%71.16%
            28.28% Insiders
            0.16% Other Institutional Investors
            71.16% Public Companies and
            Individual Investors

            Options Prices

            Currently, No data available
            ---
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis